Tachycardia-induced cardiomyopathy (TICM) can result from frequent or sustained tachyarrhythmias, including OAVRT. It is defined as myocardial dysfunction caused by a rapid ventricular rate that is completely or partially reversible after normalization of the heart rate. 5, 6 Our knowledge of APs and TICM in dogs currently is limited. Single case reports and small case series have been reported. [7] [8] [9] [10] [11] [12] [13] Radiofrequency catheter ablation (RFCA) is a minimally invasive technique targeting a tachyarrhythmic focus or reentrant circuit with radiofrequency energy to permanently disrupt that tachyarrhythmia. 14 This procedure has been reported in a small number of dogs with APs. [8] [9] [10] [11] [12] [13] Study goals were (1) describe the clinical, electrocardiographic, echocardiographic, and electrophysiologic findings in a large consecutive series of dogs with APs and (2) report RFCA procedural and long-term outcomes, with assessment of potential curative properties for RFCA in a clinical population of dogs.
| MATERIALS AND METHODS

| Animals
Eighty-nine dogs were referred to the principal author for electrophysiologic study (EPS) and RFCA of APs between September 1999
and February, 2017. Data from clinical history, CBC, serum biochemical profiles, echocardiograms, electrocardiograms, Holter monitors, and thoracic radiographs were collected by consultation with owners and referring cardiologists or internists. . 15, 16 Normalized left ventricular internal diameter at end-diastole (LVIDdN) and 2D right parasternal short-axis LA-toaortic (LA:Ao) ratio were evaluated, with dilatation defined as LVIDdN > 1.73 and 2D LA:Ao > 1.5. 15, 17, 18 The presence and severity of valvular regurgitation and concurrent congenital or acquired cardiac defects were recorded.
Twelve-lead electrocardiograms were obtained on the day of presentation, followed by telemetric monitoring until the time of discharge. Analyzed data included presence or absence of VPE (on any ECG), tachycardia cycle length, RP 0 interval during OAVRT, presence or absence of P 0 waves in the ST segment/T wave following at least some sinus complexes, other arrhythmias present before ablation, and antiarrhythmic drugs used.
| Electrophysiologic study and radiofrequency catheter ablation
Orally administered antiarrhythmic drugs were discontinued for 5 half-lives prior to EPS. Some dogs were hemodynamically unstable with their tachycardia, however, and required an IV injection of diltiazem or lidocaine to convert them to sinus rhythm within 24 hours before the procedure. Dogs were premedicated with butorphanol and midazolam, followed by anesthetic induction with etomidate, and maintenance with the lowest concentration of isoflurane needed to maintain a stable plane of anesthesia. Multielectrode catheters (Boston Scientific quadripolar fixed curve and decapolar fixed and steerable curve diagnostic electrophysiology catheters) were advanced through percutaneously placed catheter introducers in both femoral and external jugular veins to the right ventricular apex (RVA), high right atrium (HRA), His bundle region (HB), and coronary sinus (CS; Figure 1 ). 14 Electrical stimuli were delivered at twice diastolic threshold from a programmable stimulator (Bloom DTU-215 Programmable Cardiac Stimulator) to the distal electrodes of first the HRA and then RVA. Trains of 8 S1 extrastimuli followed by a progressively more premature single S2 extrastimulus were used to determine effective refractory periods, whereas incrementally faster trains of 8 extrastimuli were used to determine fastest 1-to-1 conduction properties of the AP and normal conduction system in antegrade and retrograde directions, respectively. 19 High right atrial or RVA extrastimuli were used to induce the clinical tachyarrhythmia and any other inducible rhythms. An AP was confirmed using ≥1 of these criteria: (1) by a premature RV stimulus that does not conduct to the atrium were seen with OAVRT, not atrial tachycardia. [20] [21] [22] Once the baseline EP study was completed, the HRA catheter was replaced by a 6-7F deflectable quadripolar ablation catheter In some cases with manifest preexcitation, the ventricular AP insertion was targeted during preexcited sinus rhythm. Owners were contacted annually thereafter to assess patient status. Long-term outcome and survival were assessed by identifying the date and cause of death by contacting owners, referring cardiologists, and family veterinarians. Cause of death was classified as cardiac (further divided into whether deaths were associated with APs) or noncardiac.
| Statistical analysis
Statistical analyses were performed using commercially available sta- were considered statistically significant.
3 | RESULTS
| Signalment
Twenty-three different breeds were affected ( Coughing 5
Marked weight loss/cachexia 3
Reclusive 1
Labrador breeds (27/47; P = .043). Median age at the time of presentation was 2.3 years (range, 0.33-9.7 years), with no difference between Labrador Retrievers and other breeds (P = .429). Median time from diagnosis of VPE or a narrow complex tachycardia to presentation for ablation was 4 months (range, 0.5 months to 7.8 years).
| Clinical presentation
Presenting clinical signs are shown in between presence of CHF and either fastest OAVRT cycle length before antiarrhythmic drugs (P = .374) or age at the time of ablation (P = .455). Labrador Retrievers were more likely to have biventricular CHF than non-Labrador breeds (P = .010).
Cardiac medications administered before presentation are listed in Table 2 . Thirty-eight dogs (42.7%) were taking 1-2 medications, whereas 51 dogs (57.3%) were receiving ≥3 medications. Only minor CBC and serum biochemical profile abnormalities were found, the most common being a mild increase in ALT activity (9/89 dogs).
| Electrographic findings
Narrow complex tachyarrhythmias were seen in all dogs (Table 3) . 
| Echocardiographic findings at presentation
Echocardiographic measurements are shown in Table 4 . Left ventricu- 
| Electrophysiologic study
Ninety-six APs were identified in the 87 dogs completing the mapping procedure (Table 3) . Nine dogs (10.3%) had 2 APs, whereas 78 dogs (89.7%) had a single AP. Four of 41 Labrador Retrievers (9.8%) had 2 APs, whereas 5 of 46 non-Labradors (10.9%) had 2 APs (P = 1.00).
Median OAVRT cycle length during EPS was 219 ms (range, 146-290 ms), significantly longer than that recorded in the awake state (P < 0.0001). The majority of this prolongation came from an increased P 0 R interval (Table 3) , rather than R 0 P interval, although both were pro- Accessory pathway location was distributed as shown in Figure 4 . Three surface ECG leads and eight intracardiac dipoles are displayed during radiofrequency catheter ablation (sweep speed 100 mm/s). The first 5 complexes represent orthodromic atrioventricular reciprocating tachycardia with retrograde atrial activation (labeled as A 0 in the fifth complex) over a right posteroparaseptal accessory pathway. Earliest retrograde atrial activation in these standard leads occurs in the CS 9, 10 dipole. With the sixth complex, the accessory pathway is successfully ablated, as ventricular activation (V) is not followed by retrograde atrial activation. In this dog, OAVRT terminates 3.4 s after the onset of radiofrequency energy (RF onset is not shown in this figure) , and sinus rhythm resumes after a ventricular complex. Small His bundle electrograms are marked with H. Sinus nodal activation of the atria is labeled A antegrade AV nodal pathways were identified post-ablation in 3/89 dogs, whereas dual retrograde AV nodal pathways were present in 2/89 dogs. Four dogs had single atypical AV nodal echoes during ventricular extrastimulus pacing (VA conduction over the retrograde slow pathway followed by antegrade conduction over the fast pathway).
No dog had inducible AV nodal reentrant tachycardia. Causes anesthetized OAVRT rates in our study, they are faster than in a previously reported group of 14 dogs, in which the anesthetized OAVRT rate was 229 AE 42 bpm. 34 Whereas focal atrial tachycardias (FAT) had faster ventricular rates than OAVRT in that study, median OAVRT rate in our awake dogs was substantially higher and median OAVRT rate in our anesthetized dogs was the same as the anesthetized mean FAT ventricular rate (278 bpm) in the prior study. Isoflurane can affect AV conduction as well as atrial, ventricular, and AP refractory periods. [35] [36] [37] Significant prolongation of the P 0 R interval and lesser prolongation of the R 0 P interval in the anesthetized state versus the unmedicated, awake state (Table 3) was seen in our group of dogs.
| Procedural and long-term outcomes
This finding would suggest a greater effect of general anesthesia on the AV nodal conduction system as compared to the AP. Hemodynamically compromising, incessant OAVRT in many dogs not receiving PO antiarrhythmic drugs necessitated conversion with IV diltiazem (less commonly lidocaine) the night before anesthesia.
Lingering drug effects also may have played a role in slower tachycardia cycle lengths and longer P 0 R intervals.
Retrograde P 0 waves could be seen within the ST segment of 98.8% of dogs on a 6-or 12-lead ECG, representing retrograde conduction over the AP and resulting in a short RP' interval of 80 AE 11 ms. This is similar to the RP' interval of 85 AE 16.8 ms and the frequency of identifiable P 0 waves in OAVRT reported in another study. 34 Intermittent P 0 waves in the ST segments of sinus complexes were seen in the majority of dogs (78.7%) as well. Several dogs in our study experienced paroxysmal AF before or at the time of EPS or both. A higher occurrence of AF in people with
APs has been reported, particularly in males and in those with manifest APs. 38, 39 Neither of these predilections was found in our dogs with AF. Right-sided APs and shorter OAVRT cycle lengths in children are associated with degeneration of OAVRT into AF and a higher risk of sudden death. 40 Our dogs had predominantly right-sided APs and short OAVRT cycle lengths, potentially predisposing them to AF.
The distinct predominance of right-sided APs in these dogs coincides with prior smaller studies. [7] [8] [9] [10] [11] [12] [13] Right posteroparaseptal was the most common location, followed by right free wall. This distribution is distinctly different than reported in humans, where~60% of APs are left free wall, 25% are septal pathways, and 15% are right free wall pathways. 1 Multiple APs were identified in 10% of dogs in our study, similar to the 3%-13% of human AP patients with multiple APs. [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] Five of 19 (26.3%) previously reported dogs with APs had multiple pathways. [7] [8] [9] [10] [11] [12] [13] This percentage is higher than observed in our case series or in larger studies of humans. A large retrospective study of 1088 pediatric AP patients found that congenital heart disease increased the risk of multiple APs threefold from 8% to 26% in that population. 51 Only 1 of the 9 dogs (11.1%) with congenital heart disease in our study had multiple APs.
Antegrade conduction over the AP during sinus rhythm or atrial pacing (VPE) in dogs of our study occurred less frequently than reported in humans. Antegrade AP conduction was documented in 43.8% of our dogs. This percentage is compared to 64% in a large study of children and 63%-83% in human adults. 51 55 Occurrence of TICM relates both to the rapidity and frequency of a given tachyarrhythmia. The sustained heart rate that triggers TICM is not well established in any species. It may manifest months to years after onset of the tachyarrhythmia, particularly in individuals with slower or more intermittent tachyarrhythmias. Experimental dogs and human patients with higher tachyarrhythmia rates develop TICM earlier. 55, 56 Time to onset of ventricular dysfunction also is dependent on other factors, including underlying structural heart disease and patient age. 6 We found no relationship between LV systolic dysfunction and fastest OAVRT cycle length before antiar- several large case series that support this approach. 59 These series report success rates of 93% to 95% and 3% risk of major complications in patients followed for 6 months to 8 years. 45, 46, [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] Successful RFCA eliminates the need for continued antiarrhythmic drug therapy (unless other arrhythmia substrates are present), repeated hospitalizations for tachyarrhythmia breakthrough or CHF, and lifelong follow-ups with a veterinary specialist. Given the expense associated with these factors, an RFCA procedure is economically beneficial as well. 
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